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The “acute aortic treatment center” (AATC) described and
evaluated in this article included reorganization of existing re-
sources, and a clinical pathway designed to decrease the time from
referral to definitive therapy of acute aortic syndromes to 90
minutes or less. Establishment of the AATC was accompanied by a
marketing campaign to increase referrals. The hypothesis tested by
this study was that the AATC would improve patient outcomes.
The authors achieved their goals. Compared with the year
prior to its establishment, patient volume significantly increased,
and time to definitive treatment significantly decreased. Despite
these changes, there was no improvement in patient outcomes.
This is not surprising. The pre-AATC results were already very
good, as expected from a major referral center staffed by board
certified specialists. The authors correctly noted underlying aortic
pathology was the main determinant of mortality.
So was establishment of the AATC worthwhile? Unfortu-
nately, we cannot answer this question from this study. We do notferred because of marketing. If they would not have been treated
by the most efficient/successful methods without the AATC, then
overall care was probably improved. If, on the other hand, they
would have been similarly treated at similarly equipped/staffed
referral centers (Houston is a big city; the author’s hospital is not
the only major cardiovascular center), then the AATC was a
business success but not a medical/scientific one.
One caution: Mortality for unruptured “symptomatic” aortic
aneurysms worsened post-AATC. It may be that rushing to defin-
itive treatment in these patients is dangerous, not a new finding.
The authors’ evaluation of their AATC results is admirable. Future
studies might refine the timing aspect (should the goal be 120
minutes? 180?) or attempt to look at population-wide outcomes
for the city, or county, or state (the only logical way to evaluate the
regionalization question). Moreover, perhaps the protocol should
be modified to add unruptured “symptomatic” aneurysms to the
list of excluded conditions, along with intramural hematoma,
aortic ulcer, and chronic dissections.
